TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32468672

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 97/103 mg bid
Number of subjects: 600

Group type: COMPARATOR
Intervention: enalapril 10 mg bid
Number of subjects: 600
Study: 35134798

Group type: EXPERIMENTAL
Intervention: Active laser acupuncture
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo laser acupuncture
Number of subjects: 99
Study: 34695090

Group type: EXPERIMENTAL
Intervention: Social-norm-based intervention (letter mailed to GPs with prescribing data comparison)
Number of subjects: 1214

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1214
Study: 32859392

Group type: EXPERIMENTAL
Intervention: Heparin-bonded polytetrafluoroethylene
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard polytetrafluoroethylene
Number of subjects: 105
Study: 34495337

Group type: COMPARATOR
Intervention: Screening before lockdown (November 11, 2019, to March 9, 2020)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Screening after lockdown (May 14 to September 3, 2020)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High ctDNA concentration (after lockdown)
Number of subjects: 80
Study: 20073016717

Group type: EXPERIMENTAL
Intervention: Beta-glucuronidase (BG) treatment
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 35602349

Group type: EXPERIMENTAL
Intervention: Dapagliflozin combined with lifestyle intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lifestyle intervention
Number of subjects: 80
Study: 34024294

Group type: EXPERIMENTAL
Intervention: Cognitively-Based Compassion Training (CBCT®)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 56
Study: 33783339

Group type: EXPERIMENTAL
Intervention: Training program for PEP prescription guidelines
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Computer-based decision program (CBDP)
Number of subjects: 20
Study: 33581954

Group type: EXPERIMENTAL
Intervention: Injectable platelet‐rich fibrin (İ‐PRF) in addition to arthrocentesis
Number of subjects: 36

Group type: COMPARATOR
Intervention: Arthrocentesis alone (Control)
Number of subjects: 36
Study: 35927740

Group type: EXPERIMENTAL
Intervention: Customized adherence enhancement (CAE) delivered via telehealth communications, comprising up to four standard treatment modules: Psychoeducation, Communication with Providers, Medication Routines, and Modified Motivational Interviewing.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Customized adherence enhancement (CAE)
Number of subjects: 0
Study: 32066104

Group type: EXPERIMENTAL
Intervention: Repetitive finger tapping in Alzheimer's patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Short-latency afferent inhibition assessment in Alzheimer's patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Frontal Assessment Battery scores in Alzheimer's patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cortical cholinergic deficit in Alzheimer's patients
Number of subjects: 20
Study: 35191790

Group type: EXPERIMENTAL
Intervention: Healing Touch Chakra Connection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healing Touch Video
Number of subjects: 0
Study: 33010046

Group type: EXPERIMENTAL
Intervention: Pharmacokinetically guided dosing of pazopanib
Number of subjects: 25

Group type: COMPARATOR
Intervention: Historical controls (12 patients not receiving TDM)
Number of subjects: 25
Study: 32898024

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 100
Study: 34617261

Group type: EXPERIMENTAL
Intervention: Allopurinol 20 mg/kg (first dose), 10 mg/kg (second dose if undergoing therapeutic hypothermia)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Allopurinol and oxypurinol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Oxypurinol
Number of subjects: 46
Study: 32131074

Group type: EXPERIMENTAL
Intervention: Nursing interventions based on the Extended Theory of Planned Behavior (ETPB) including pre-operative patient education, goal setting, and feedback from the day before surgery to 12 months after lung resection
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Nursing interventions based on the Extended Theory of Planned Behavior (ETPB)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 87
Study: 35817197

Group type: EXPERIMENTAL
Intervention: Active inhibitory transcranial direct current stimulation (tDCS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo cathodal stimulation
Number of subjects: 16
Study: 34304604

Group type: EXPERIMENTAL
Intervention: Aspirin-clopidogrel
Number of subjects: 37087

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 37087

Group type: EXPERIMENTAL
Intervention: Aspirin-dipyridamole
Number of subjects: 37087

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 37087
Study: 32645078

Group type: EXPERIMENTAL
Intervention: HBV screening
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Full vaccination against HBV
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Public healthcare facility
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Belief that HBV vaccine was safe
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Ever been screened for HBV
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Self-perceived risk of HBV infection
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Healthcare facility with infection control guidelines
Number of subjects: 306
Study: 34209422

Group type: EXPERIMENTAL
Intervention: Fusarium proliferatum strains
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: F. brachygibbosum strains
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Fusarium caatingaense, F. clavum, F. incarnatum
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Fusarium solani strains
Number of subjects: 63
Study: 32127214

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34379121

Group type: COMPARATOR
Intervention: 5% fluoride
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10% xylitol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20% xylitol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 36255730

Group type: EXPERIMENTAL
Intervention: Gram stain-guided initial antibiotic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guideline-based group
Number of subjects: 0
Study: 34107720

Group type: EXPERIMENTAL
Intervention: Combined supplementation with vitamin D (40,000 IU) and omega-3 fatty acids (8,000 mg) twice a day for 6 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 150
Study: 33048667

Group type: EXPERIMENTAL
Intervention: Transcranial near-infrared photobiomodulation (tNIR-PBM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study: 33169443

Group type: COMPARATOR
Intervention: Control group saw existing industry-standard labels
Number of subjects: 7516

Group type: EXPERIMENTAL
Intervention: Pictograph container design
Number of subjects: 7516

Group type: EXPERIMENTAL
Intervention: Pictograph serving design
Number of subjects: 7516

Group type: EXPERIMENTAL
Intervention: Pie-chart serving design
Number of subjects: 7516

Group type: EXPERIMENTAL
Intervention: Food label serving design
Number of subjects: 7516
Study: 32229541

Group type: EXPERIMENTAL
Intervention: Pulmonary tele-rehabilitation (PTR) for 10 weeks (60 min, three times weekly)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional pulmonary rehabilitation (PR) for 10 weeks (90 min, two times weekly)
Number of subjects: 134
Study: 34978887

Group type: EXPERIMENTAL
Intervention: Gepotidacin 1,500‐mg oral dose twice daily for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active comparator (not specified)
Number of subjects: 0
Study: 33260235

Group type: EXPERIMENTAL
Intervention: Telemedical anticoagulation service (CS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular medical care (RMC)
Number of subjects: 30
Study: 34892649

Group type: EXPERIMENTAL
Intervention: P‐Pong (proprioceptive training group)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (video‐only version of Pong)
Number of subjects: 15
Study: 36328325

Group type: EXPERIMENTAL
Intervention: Life Satisfaction (LS)
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: Day Affect (DA)
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Control group (functional description of health states)
Number of subjects: 1259
Study: 33226332

Group type: EXPERIMENTAL
Intervention: Solriamfetol 37.5 mg, 75 mg, 150 mg, or 300 mg
Number of subjects: 690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study: 36427815

Group type: EXPERIMENTAL
Intervention: Active LF‐rTMS
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham LF‐rTMS
Number of subjects: 19
Study: 33369253

Group type: EXPERIMENTAL
Intervention: Leg heat therapy (HT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment (C)
Number of subjects: 16
Study: 32955455

Group type: EXPERIMENTAL
Intervention: Mobile health (mHealth): entertaining educational audio capsules and voice immunization reminders via mobile phone
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Face-to-face: community mobilization activities, including 3 small group meetings
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: mHealth strategy
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 387

Group type: COMPARATOR
Intervention: Control group (usual services)
Number of subjects: 387
Study: 32290787

Group type: EXPERIMENTAL
Intervention: TMD + Nuts
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: TMD + VOO
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control diet (low-fat diet recommendations)
Number of subjects: 34
Study: 33741520

Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-yoga group
Number of subjects: 70
Study: 36066319

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (RBCs transfused when hemoglobin <7.5 g/dl)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfusion triggers: <9.5 g/L intraoperatively, <9.5 g/L in intensive care, <8.5 g/dl on the ward)
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 617

Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 617
Study: 33826087

Group type: EXPERIMENTAL
Intervention: Tell‐Show‐Do Technique (TSD‐T)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Hiding Dental‐Needle Technique (HDN‐T)
Number of subjects: 52
Study: 34418670

Group type: EXPERIMENTAL
Intervention: NMES + exercise therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 50
Study: 32049561

Group type: EXPERIMENTAL
Intervention: Submandibular gland duct graft
Number of subjects: 28

Group type: COMPARATOR
Intervention: Vein graft
Number of subjects: 28
Study: 33651730

Group type: EXPERIMENTAL
Intervention: Flat SIT training (n = 9)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Uphill SIT training (6% gradient, n = 9)
Number of subjects: 18
Study: 33402575

Group type: EXPERIMENTAL
Intervention: Topical Betamethasone Valerate 0.1% cream, applied twice daily during radiotherapy/chemo-radiotherapy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (arm B)
Number of subjects: 106
Study: 32665218

Group type: EXPERIMENTAL
Intervention: Robotic ventral hernia repair (n=65)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Laparoscopic ventral hernia repair (n=59)
Number of subjects: 124
Study: 35199419

Group type: EXPERIMENTAL
Intervention: Value-based counselling (VBC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 103
Study: 32543287

Group type: EXPERIMENTAL
Intervention: Clinical predictive scoring system established from model group analysis.
Number of subjects: 236

Group type: COMPARATOR
Intervention: Model group analysis (incision-infection group vs non-infection group).
Number of subjects: 236
Study: 35550854

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 190
Study: 33902072

Group type: EXPERIMENTAL
Intervention: Ampicillin, gentamicin, and metronidazole (group 1)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ampicillin, gentamicin, and clindamycin (group 2)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Piperacillin‐tazobactam and gentamicin (group 3)
Number of subjects: 180

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 180
Study: 35089205

Group type: EXPERIMENTAL
Intervention: Antibiotic cement coating group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 33832490

Group type: EXPERIMENTAL
Intervention: Combination therapy of periodontal curettage and root planing
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Periodontal curettage
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cleansing
Number of subjects: 72
Study: 33686187

Group type: EXPERIMENTAL
Intervention: Premature-born adults
Number of subjects: 101

Group type: COMPARATOR
Intervention: Full-term controls
Number of subjects: 101
Study: 33032164

Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (biomass cooking)
Number of subjects: 180
Study: 35172071

Group type: EXPERIMENTAL
Intervention: Cytoreductive Surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33054737

Group type: EXPERIMENTAL
Intervention: Schema therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Individual supportive therapy
Number of subjects: 300
Study: 34257352

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Control group (randomly assigned)
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: HER2 Ile655Val polymorphism
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Patient characteristics
Number of subjects: 1056
Study: 33070366

Group type: EXPERIMENTAL
Intervention: TAC/MMF
Number of subjects: 150

Group type: COMPARATOR
Intervention: TAC/SRL
Number of subjects: 150

Group type: COMPARATOR
Intervention: CSA/SRL
Number of subjects: 150

Group type: COMPARATOR
Intervention: TAC/SRL and CSA/SRL
Number of subjects: 150
Study: 35385050

Group type: EXPERIMENTAL
Intervention: Canakinumab (50, 150, and 300 mg once every 3 months)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study: 32453275

Group type: EXPERIMENTAL
Intervention: Pronine‐alanine‐valine homozygous haplotype
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Genotype
Number of subjects: 42
Study: 33011715

Group type: EXPERIMENTAL
Intervention: Experimental condition (n = 46) - four-week online intervention promoting analytical thinking through the Gamblers Fallacy Questionnaire
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control condition (n = 48)
Number of subjects: 94
Study: 35954937

Group type: EXPERIMENTAL
Intervention: Seawater hydration (Totum SPORT, Laboratories Quinton International, S.L., Valencia, Spain)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Tap water (ad libitum)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Physiologic saline solution (placebo)
Number of subjects: 15
Study: 33533155

Group type: EXPERIMENTAL
Intervention: 2.5% agarose gel
Number of subjects: 66

Group type: COMPARATOR
Intervention: NASHA-L
Number of subjects: 66

Group type: COMPARATOR
Intervention: 2.5% agarose gel and NASHA-L
Number of subjects: 66
Study: 32853585

Group type: EXPERIMENTAL
Intervention: Ipilimumab group (brentuximab vedotin 1.8 mg/kg with ipilimumab 1 mg/kg or 3 mg/kg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nivolumab group (brentuximab vedotin 1.2 mg/kg or 1.8 mg/kg with nivolumab 3 mg/kg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Triplet therapy group (brentuximab vedotin 1.2 mg/kg or 1.8 mg/kg with nivolumab 3 mg/kg and ipilimumab 1 mg/kg)
Number of subjects: 61
Study: 34112001

Group type: EXPERIMENTAL
Intervention: Taurolock‐hep500™ as a catheter lock solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unfractionated heparin as a catheter lock solution
Number of subjects: 60
Study: 34656191

Group type: EXPERIMENTAL
Intervention: SET‐C (Social Effectiveness Therapy for Children)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Pegasys‐VR™
Number of subjects: 63
Study: 32256897

Group type: EXPERIMENTAL
Intervention: Medication review service (delivered by clinical pharmacists)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no medication review service)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All refugee patients (both groups)
Number of subjects: 106
Study: 35777814

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 119
Study: 34092002

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided quadratus lumborum block combined with general anaesthesia
Number of subjects: 76
Study: 32075675

Group type: EXPERIMENTAL
Intervention: START initiative
Number of subjects: 61
Study: 34505555

Group type: EXPERIMENTAL
Intervention: Online adaptive attention training (SAT) for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Working memory training (WMT) for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waitlist (WL) for 4 weeks
Number of subjects: 80
Study: 34289820

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed formula (EHF) at 2.4 g protein/100 kcal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amino acid-based formula (AAF) at 2.4 g total protein equivalents/100 kcal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (EH casein formula at 2.8 g protein/100 kcal)
Number of subjects: 0
Study: 34528408

Group type: EXPERIMENTAL
Intervention: Repository corticotropin injection (RCI; 80 IU subcutaneously twice weekly on study days 1 and 4)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Synthetic ACTH1-24 depot (1 mg subcutaneously twice weekly on study days 1 and 4)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Methylprednisolone (32 mg orally once daily on study days 1 through 6)
Number of subjects: 48
Study: 35186225

Group type: EXPERIMENTAL
Intervention: High-quality nursing intervention based on humanistic care combined with the project teaching method (EG)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Routine nursing during chemotherapy (CG)
Number of subjects: 114
Study: 35044988

Group type: EXPERIMENTAL
Intervention: Decision tree model
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Random forest model
Number of subjects: 710
Study: 33507984

Group type: EXPERIMENTAL
Intervention: Annual caries preventive intervention including placement of fissure sealants, application of povidone-iodine and fluoride varnish, and standard diet and oral hygiene advice.
Number of subjects: 408

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 408
Study: 36036106

Group type: EXPERIMENTAL
Intervention: Intranasal acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 80
Study: 32677847

Group type: COMPARATOR
Intervention: TCONS_00483150
Number of subjects: 0
Study: 35604760

Group type: EXPERIMENTAL
Intervention: Well-Care Visit (WCV)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: WCV with CBT app
Number of subjects: 217

Group type: COMPARATOR
Intervention: WCV
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: CBT app
Number of subjects: 217
Study: 33237903

Group type: EXPERIMENTAL
Intervention: Neural network algorithm for skin cancer detection (AUC 0.863) using unprocessed clinical photographs.
Number of subjects: 10426

Group type: COMPARATOR
Intervention: First clinical impression of 65 attending physicians.
Number of subjects: 10426

Group type: EXPERIMENTAL
Intervention: Neural network algorithm for batches of 30 patients.
Number of subjects: 10426

Group type: COMPARATOR
Intervention: First impression of 44 dermatologists in reader test.
Number of subjects: 10426
Study: 35351124

Group type: EXPERIMENTAL
Intervention: TIME intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 40
Study: 34089578

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 885

Group type: COMPARATOR
Intervention: Medical Therapy
Number of subjects: 885
Study: 33139757

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Bifidobacterium-animalis-subsp.-Lactis 10×10^9 and Lactobacillus-Acidophilus 10×10^9 + 5 g of maltodextrin)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (5 g of maltodextrin)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 27
Study: 34425251

Group type: EXPERIMENTAL
Intervention: 15-lb weighted blanket
Number of subjects: 94

Group type: COMPARATOR
Intervention: 5-lb weighted blanket
Number of subjects: 94
Study: 32185522

Group type: EXPERIMENTAL
Intervention: Beta distribution-based approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard continuous analysis approach
Number of subjects: 0
Study: 33952318

Group type: EXPERIMENTAL
Intervention: ICU-specific virtual reality (ICU-VR) intervention offered 3 months after hospital discharge
Number of subjects: 80

Group type: COMPARATOR
Intervention: ICU-specific virtual reality (ICU-VR) intervention offered 6 months after hospital discharge (late ICU-VR)
Number of subjects: 80
Study: 32541620

Group type: EXPERIMENTAL
Intervention: Dynamic Work (DW) Intervention
Number of subjects: 244

Group type: COMPARATOR
Intervention: Usual Practice (Control)
Number of subjects: 244
Study: 33478302

Group type: EXPERIMENTAL
Intervention: Experimental group with diversified and quantitative exercise intervention management mode (at least 30 min per day, not less than 150 min per week)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group with conventional sports
Number of subjects: 138
Study: 33662491

Group type: EXPERIMENTAL
Intervention: D-CLIP intervention
Number of subjects: 573
Study: 35776441

Group type: EXPERIMENTAL
Intervention: HIV and STI testing
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: HIV testing
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: STI testing
Number of subjects: 414